LRP5 and colitis: The microbiome has been implicated as a driver of inflammation in mice with LRP5/6-deficient CD11c+ APCs with expression of a stabilized form of β-catenin specifically in CD11c+ APCs ameliorating disease pathology and pro-inflammatory responses in the DSS colitis model (144).